2026 NPPES data Pediatric Endocrinology Physician NPI 1861593170 M.D.
Verify on CMS →

STEVEN WAGUESPACK, M.D.

Pediatric Endocrinology Physician in HOUSTON, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
408
Medicare Part D claims · 101 beneficiaries · Pediatric Endocrinology Physician avg: 151
Generic prescribing
51%
generic claims · 49% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
81.3897/100
▼ 2 pts below national avg 83.1 · [object Object]
Industry payments
$5.9K
3 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

STEVEN WAGUESPACK, M.D. reported a CMS MIPS final score of 81.3897/100 — below the 83.1 national average — and filed 408 Medicare Part D claims in 2023.

81.3897/100
MIPS score · -2 vs avg
408
Part D claims, 2023
51%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

STEVEN WAGUESPACK, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

81 36th percentile higher than 36% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

STEVEN WAGUESPACK, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about STEVEN WAGUESPACK, M.D.?

Near national average

NPI registry status

Active

Issued 09/26/2006

NPI 1861593170

Primary specialty

Pediatric Endocrinology Physician

Niche

1,457 US NPIs in this specialty

Medicare Part D claims

408 170% vs specialty avg

2023 prescription claims

Specialty avg: 151

MIPS final score

81.3897/100 1.7102999999999895% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Texas

How Pediatric Endocrinology Physician compares to other specialties among Texas providers

Texas providers

Pediatric Endocrinology Physician share within Texas

1. Pediatric Endocrinology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pediatric Endocrinology Physician share within Texas

Medicare quality performance — MIPS

STEVEN WAGUESPACK, M.D.'s 2023 MIPS final score plotted against the Pediatric Endocrinology Physician national average

Near national average
MIPS Final Score
81.3897/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Pediatric Endocrinology Physician) — 81.3897/100 vs national avg 83.1

0%100%National avg83%81.4%
MIPS final score (Pediatric Endocrinology Physician) — 81.3897/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

STEVEN WAGUESPACK, M.D. appears in the CMS NPPES registry as a Pediatric Endocrinology Physician provider holding M.D. credentials at 1515 HOLCOMBE BLVD, HOUSTON, TX, 77030, with a listed phone of (713) 792-6161. NPI 1861593170 was issued on 09/26/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WAGUESPACK most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 408 prescription claims written by this provider, covering 101 Medicare beneficiaries and totaling roughly $1.4 million in drug spend, split 49% brand-name and 51% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 81.3897/100 for the 2023 performance year (Quality 81.2519, Cost 49.9786), compared with the national average of 83.1.

Pediatric Endocrinology Physician is a narrow specialty nationwide, with 1,457 enrolled providers across 51 states and an average of 151 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1515 HOLCOMBE BLVD
HOUSTON, TX 77030

Provider Details

NPI 1861593170
Specialty Pediatric Endocrinology Physician
Credentials M.D.
Gender Male
NPI Issued 09/26/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

81.3897
Final Score
Avg: 83.1
81.2519
Quality
49.9786
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where STEVEN WAGUESPACK, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

PHYSICIANS REFERRAL SERVICE
HOUSTON, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for STEVEN WAGUESPACK, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$5.9K

Largest payer

Bayer Healthcare Pharmaceuticals Inc.

Most common payment type

Consulting Fee

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to STEVEN WAGUESPACK, M.D.. To verify STEVEN WAGUESPACK, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

STEVEN WAGUESPACK, M.D. — brand share 49.0%
Specialty average (est.)

49% brand-name claims vs 51% generic, on 408 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

408
Total Claims
$1.4M
Total Drug Cost
101
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
863
Total Day Supply
25,328
Brand vs Generic
49% brand / 51% generic
Brand Drug Cost
$1.3M
Generic Drug Cost
$10K

Patient Demographics

Average Patient Age
68.0 years
Avg HCC Risk Score
2.46
Gender Split
53% female / 47% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What STEVEN WAGUESPACK, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
91
Synthroid
Levothyroxine Sodium
29
Hydrocortisone
27
Tafinlar
Dabrafenib Mesylate
27
Liothyronine Sodium
21
Mekinist
Trametinib Dimethyl Sulfoxide
14
Retevmo
Selpercatinib
14
Votrient
Pazopanib Hcl
13
Testosterone
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pediatric Endocrinology Physician Overview

How STEVEN WAGUESPACK, M.D. fits within the Pediatric Endocrinology Physician landscape nationally.

1,457
Pediatric Endocrinology Physician Providers in US
51
States with Pediatric Endocrinology Physician
151
Avg Claims per Provider

STEVEN WAGUESPACK, M.D.'s 408 claims are above the specialty average of 151.

Nearby Pediatric Endocrinology Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as WAGUESPACK.

Compare Pediatric Endocrinology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is STEVEN WAGUESPACK, M.D.'s specialty?
STEVEN WAGUESPACK, M.D. specializes in Pediatric Endocrinology Physician and practices in HOUSTON, Texas. Credentials: M.D..
How much does STEVEN WAGUESPACK, M.D. prescribe under Medicare Part D?
In 2023, STEVEN WAGUESPACK, M.D. wrote 408 Medicare Part D claims totaling $1.4M in drug costs for 101 beneficiaries.
What is STEVEN WAGUESPACK, M.D.'s Medicare quality score?
STEVEN WAGUESPACK, M.D. has a CMS MIPS Final Score of 81.3897/100 (Quality: 81.2519, Cost: 49.9786). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is STEVEN WAGUESPACK, M.D. located?
STEVEN WAGUESPACK, M.D. is located at 1515 HOLCOMBE BLVD, HOUSTON, TX, 77030. Phone: (713) 792-6161.
What is STEVEN WAGUESPACK, M.D.'s NPI number?
STEVEN WAGUESPACK, M.D.'s National Provider Identifier (NPI) is 1861593170, issued on 09/26/2006.
Does STEVEN WAGUESPACK, M.D. prescribe more brand-name or generic drugs?
STEVEN WAGUESPACK, M.D.'s prescribing is 49% brand-name and 51% generic drugs by claim count, with $1.3M in brand drug costs.
How many Pediatric Endocrinology Physician providers are there in the US?
There are 1,457 Pediatric Endocrinology Physician providers across 51 states in the US. The average Pediatric Endocrinology Physician provider writes 151 Medicare Part D claims per year.
What drugs does STEVEN WAGUESPACK, M.D. prescribe most often?
Based on 2023 Medicare Part D data, STEVEN WAGUESPACK, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Synthroid, Hydrocortisone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does STEVEN WAGUESPACK, M.D. accept Medicare?
STEVEN WAGUESPACK, M.D. appears in CMS Medicare data with 408 Part D claims and 101 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify STEVEN WAGUESPACK, M.D.'s credentials?
STEVEN WAGUESPACK, M.D.'s NPI is 1861593170 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology